Overnight news ICYMI: Gilead plans to produce two million remdesivir coronavirus course by the end of 2020

Gilead Sciences planning to produce the amount of its potential COVID-19 drug remdesivir by the end of the year 
– It says it'll begin trial of an easier-to-use inhaled version in August (its currently administered intravenously)
This was out overnight, not fresh news,